Skip to main content
RAPS Convergence 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Requires Pre-Registration or Sign-up
Requires Pre-Registration or Sign-up
Additional Registration Fee
Additional Registration Fee
Invitation Only
Invitation Only
Student Program
Student Program
Networking Opportunity
Networking Opportunity
RAPS Focus Area
RAPS Focus Area
Back
Evaluation ViewAttendees 38

Devices (includes Medical Devices and In Vitro Diagnostics)

Drug-Device Combination Products: The Why Behind the Regulatory Strategy

Thursday, October 5, 2023
8:00 AM – 9:15 AM EDT
Location/Room: 510B
Important considerations for regulatory submissions in the US and EU when a drug-device combination integral product is co-packaged or cross-labelled/referenced with one or more devices.

Learning Objectives:

  • Key strategies for medical device companies to consider.
  • Key information for pharma companies to consider providing.
  • Tips for preparing robust regulatory submissions to health authorities.